Dr. Verma on Treatments in the Neoadjuvant Setting of HER2-Positive Breast Cancer
October 13th 2016
Sunil Verma, MD, department head, Clinical Department of Oncology, Calgary Zone, medical director, Tom Baker Cancer Centre, discusses the overall treatment paradigm in the neoadjuvant setting of HER2-positive breast cancer.